Literature DB >> 33761980

CACTUS: integrating clonal architecture with genomic clustering and transcriptome profiling of single tumor cells.

Shadi Darvish Shafighi1, Szymon M Kiełbasa2, Cornelis A M van Bergen3, Ewa Szczurek1, Julieta Sepúlveda-Yáñez3, Ramin Monajemi2, Davy Cats2, Hailiang Mei2, Roberta Menafra4, Susan Kloet4, Hendrik Veelken3.   

Abstract

BACKGROUND: Drawing genotype-to-phenotype maps in tumors is of paramount importance for understanding tumor heterogeneity. Assignment of single cells to their tumor clones of origin can be approached by matching the genotypes of the clones to the mutations found in RNA sequencing of the cells. The confidence of the cell-to-clone mapping can be increased by accounting for additional measurements. Follicular lymphoma, a malignancy of mature B cells that continuously acquire mutations in parallel in the exome and in B cell receptor loci, presents a unique opportunity to join exome-derived mutations with B cell receptor sequences as independent sources of evidence for clonal evolution.
METHODS: Here, we propose CACTUS, a probabilistic model that leverages the information from an independent genomic clustering of cells and exploits the scarce single cell RNA sequencing data to map single cells to given imperfect genotypes of tumor clones.
RESULTS: We apply CACTUS to two follicular lymphoma patient samples, integrating three measurements: whole exome, single-cell RNA, and B cell receptor sequencing. CACTUS outperforms a predecessor model by confidently assigning cells and B cell receptor-based clusters to the tumor clones.
CONCLUSIONS: The integration of independent measurements increases model certainty and is the key to improving model performance in the challenging task of charting the genotype-to-phenotype maps in tumors. CACTUS opens the avenue to study the functional implications of tumor heterogeneity, and origins of resistance to targeted therapies. CACTUS is written in R and source code, along with all supporting files, are available on GitHub ( https://github.com/LUMC/CACTUS ).

Entities:  

Keywords:  B cell receptor; Clonal evolution; Follicular lymphoma; Probabilistic graphical model; Single-cell sequencing; Somatic mutations

Mesh:

Year:  2021        PMID: 33761980      PMCID: PMC7988935          DOI: 10.1186/s13073-021-00842-w

Source DB:  PubMed          Journal:  Genome Med        ISSN: 1756-994X            Impact factor:   11.117


  31 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.

Authors:  Florian Scherer; Marcelo A Navarrete; Cristina Bertinetti-Lapatki; Joachim Boehm; Annette Schmitt-Graeff; Hendrik Veelken
Journal:  Leuk Lymphoma       Date:  2015-05-18

Review 3.  Molecular pathogenesis of germinal center-derived B cell lymphomas.

Authors:  Laura Pasqualucci
Journal:  Immunol Rev       Date:  2019-03       Impact factor: 12.988

Review 4.  Computational cluster validation in post-genomic data analysis.

Authors:  Julia Handl; Joshua Knowles; Douglas B Kell
Journal:  Bioinformatics       Date:  2005-05-24       Impact factor: 6.937

5.  Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma.

Authors:  Itay Tirosh; Andrew S Venteicher; Christine Hebert; Leah E Escalante; Anoop P Patel; Keren Yizhak; Jonathan M Fisher; Christopher Rodman; Christopher Mount; Mariella G Filbin; Cyril Neftel; Niyati Desai; Jackson Nyman; Benjamin Izar; Christina C Luo; Joshua M Francis; Aanand A Patel; Maristela L Onozato; Nicolo Riggi; Kenneth J Livak; Dave Gennert; Rahul Satija; Brian V Nahed; William T Curry; Robert L Martuza; Ravindra Mylvaganam; A John Iafrate; Matthew P Frosch; Todd R Golub; Miguel N Rivera; Gad Getz; Orit Rozenblatt-Rosen; Daniel P Cahill; Michelle Monje; Bradley E Bernstein; David N Louis; Aviv Regev; Mario L Suvà
Journal:  Nature       Date:  2016-11-02       Impact factor: 69.504

6.  PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.

Authors:  Amit G Deshwar; Shankar Vembu; Christina K Yung; Gun Ho Jang; Lincoln Stein; Quaid Morris
Journal:  Genome Biol       Date:  2015-02-13       Impact factor: 13.583

Review 7.  Using single-cell multiple omics approaches to resolve tumor heterogeneity.

Authors:  Michael A Ortega; Olivier Poirion; Xun Zhu; Sijia Huang; Thomas K Wolfgruber; Robert Sebra; Lana X Garmire
Journal:  Clin Transl Med       Date:  2017-12-28

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.

Authors:  Jean Fan; Hae-Ock Lee; Soohyun Lee; Da-Eun Ryu; Semin Lee; Catherine Xue; Seok Jin Kim; Kihyun Kim; Nikolaos Barkas; Peter J Park; Woong-Yang Park; Peter V Kharchenko
Journal:  Genome Res       Date:  2018-06-13       Impact factor: 9.043

10.  Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference.

Authors:  Yuanhua Huang; Davis J McCarthy; Oliver Stegle
Journal:  Genome Biol       Date:  2019-12-13       Impact factor: 13.583

View more
  2 in total

1.  Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer.

Authors:  Haoyun Lei; Xiaoyan A Guo; Yifeng Tao; Kai Ding; Xuecong Fu; Steffi Oesterreich; Adrian V Lee; Russell Schwartz
Journal:  Bioinformatics       Date:  2022-06-24       Impact factor: 6.931

Review 2.  Applicability of spatial transcriptional profiling to cancer research.

Authors:  Rania Bassiouni; Lee D Gibbs; David W Craig; John D Carpten; Troy A McEachron
Journal:  Mol Cell       Date:  2021-04-06       Impact factor: 17.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.